Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

Mark E. Cooper; Silvio E. Inzucchi; Bernard Zinman; Stefan Hantel; Maximilian von Eynatten; Christoph Wanner; Audrey Koitka-Weber

doi:10.1053/j.ajkd.2019.03.432

Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

Mark E. Cooper, Silvio E. Inzucchi, Bernard Zinman, Stefan Hantel, Maximilian von Eynatten, Christoph Wanner, Audrey Koitka-Weber

Diabetes

Research output: Contribution to journal › Letter › Other › peer-review

24 Citations (Scopus)

Original language	English
Pages (from-to)	713-715
Number of pages	3
Journal	American Journal of Kidney Diseases
Volume	74
Issue number	5
DOIs	https://doi.org/10.1053/j.ajkd.2019.03.432
Publication status	Published - Nov 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.ajkd.2019.03.432

Cite this

@article{e5a3d90354fd4dc9b4581dd47d927e81,

title = "Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial",

author = "Cooper, {Mark E.} and Inzucchi, {Silvio E.} and Bernard Zinman and Stefan Hantel and {von Eynatten}, Maximilian and Christoph Wanner and Audrey Koitka-Weber",

year = "2019",

month = nov,

doi = "10.1053/j.ajkd.2019.03.432",

language = "English",

volume = "74",

pages = "713--715",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "Elsevier",

number = "5",

}

Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes : An Analysis From the EMPA-REG OUTCOME Trial. / Cooper, Mark E.; Inzucchi, Silvio E.; Zinman, Bernard; Hantel, Stefan; von Eynatten, Maximilian; Wanner, Christoph; Koitka-Weber, Audrey.

In: American Journal of Kidney Diseases, Vol. 74, No. 5, 11.2019, p. 713-715.

Research output: Contribution to journal › Letter › Other › peer-review

TY - JOUR

T1 - Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes

T2 - An Analysis From the EMPA-REG OUTCOME Trial

AU - Cooper, Mark E.

AU - Inzucchi, Silvio E.

AU - Zinman, Bernard

AU - Hantel, Stefan

AU - von Eynatten, Maximilian

AU - Wanner, Christoph

AU - Koitka-Weber, Audrey

PY - 2019/11

Y1 - 2019/11

UR - http://www.scopus.com/inward/record.url?scp=85073012976&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2019.03.432

DO - 10.1053/j.ajkd.2019.03.432

M3 - Letter

C2 - 31255334

AN - SCOPUS:85073012976

VL - 74

SP - 713

EP - 715

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5

ER -

Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

UN SDGs

Access to Document

Other files and links

Cite this